CBL114F
Mouse Anti-Human IgA Antibody, clone M24A, heavy chain, FITC conjugated
clone M24A, Chemicon®, from mouse
Sinônimo(s):
Anti-human IgA FITC
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Produtos recomendados
fonte biológica
mouse
Nível de qualidade
conjugado
FITC conjugate
forma do anticorpo
purified immunoglobulin
tipo de produto de anticorpo
secondary antibodies
clone
M24A, monoclonal
reatividade de espécies
human
fabricante/nome comercial
Chemicon®
técnica(s)
ELISA: suitable
flow cytometry: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
Isotipo
IgG1
Condições de expedição
wet ice
modificação pós-traducional do alvo
unmodified
Categorias relacionadas
Especificidade
This antibody is specific for the heavy chain of human immunoglobulin A, and shows no cross-reactivity with intact human IgM or IgG, kappa or lambda light chains
Aplicação
Immunohistological staining of IgA expressing cells in tissue sections.
Identification of surface IgA on B lymphocytes by direct Immunofluorescence.
ELISA
Flow Cytometry
Optimal working dilutions must be determined by the end user.
Identification of surface IgA on B lymphocytes by direct Immunofluorescence.
ELISA
Flow Cytometry
Optimal working dilutions must be determined by the end user.
Research Category
Secondary & Control Antibodies
Secondary & Control Antibodies
Research Sub Category
Fragment Specific Secondary Antibodies
Fragment Specific Secondary Antibodies
This Mouse anti-Human IgA Antibody, clone M24A, heavy chain, FITC conjugated is validated for use in ELISA, FC, IF, IH for the detection of Human IgA.
forma física
The conjugate is supplied in phosphate buffered saline containing 10mM sodium azide and 1mg/ml bovine serum albumin. For flow cytometry we recommend using 10μL of conjugate per test.
Armazenamento e estabilidade
Store at +4°C protected from light. DO NOT FREEZE. For long term use and storage aliquot conjugate into small volumes and store at +4°C for up to one year.
Informações legais
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Exoneração de responsabilidade
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Ferramenta de seleção de produtos.
Código de classe de armazenamento
12 - Non Combustible Liquids
Classe de risco de água (WGK)
WGK 2
Ponto de fulgor (°F)
Not applicable
Ponto de fulgor (°C)
Not applicable
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Philip A Mudd et al.
Cell, 185(4), 603-613 (2022-01-14)
SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4+ T cell responses. It is not yet clear whether vaccine-induced follicular helper CD4+ T (TFH) cell responses contribute to this outstanding immunogenicity. Using fine-needle aspiration of draining axillary lymph nodes from
Jackson S Turner et al.
Nature, 595(7867), 421-425 (2021-05-25)
Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies1-7. Individuals who have recovered from COVID-19 have a substantially lower risk of reinfection with SARS-CoV-28-10. Nonetheless, it has been reported that levels of anti-SARS-CoV-2 serum
SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
Alsoussi, et al.
Nature, 617, 592-598 (2023)
Jackson S Turner et al.
Nature, 596(7870), 109-113 (2021-06-29)
SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-191-5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells induced by these vaccines in humans remain unclear. Here we examined antigen-specific B cell responses in peripheral blood (n = 41) and draining lymph
Joana P Bernardes et al.
Immunity, 53(6), 1296-1314 (2020-12-10)
Temporal resolution of cellular features associated with a severe COVID-19 disease trajectory is needed for understanding skewed immune responses and defining predictors of outcome. Here, we performed a longitudinal multi-omics study using a two-center cohort of 14 patients. We analyzed
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica